A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine

被引:59
|
作者
Hinkson, Izumi V. [1 ,2 ]
Davidsen, Tanja M. [1 ]
Klemm, Juli D. [1 ]
Chandramouliswaran, Ishwar [3 ]
Kerlavage, Anthony R. [1 ]
Kibbe, Warren A. [1 ,4 ]
机构
[1] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20850 USA
[2] Amer Assoc Advancement Sci, Sci & Technol Policy Fellowship Program, Washington, DC USA
[3] NIAID, Off Genom & Adv Technol, 9000 Rockville Pike, Bethesda, MD 20892 USA
[4] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2017年 / 5卷
基金
美国国家卫生研究院;
关键词
genomics; proteomics; imaging; big data; cancer; precision medicine; cloud infrastructure; PROTEOGENOMIC CHARACTERIZATION; GENOMIC CHARACTERIZATION;
D O I
10.3389/fcell.2017.00083
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Advancements in next-generation sequencing and other -omics technologies are accelerating the detailed molecular characterization of individual patient tumors, and driving the evolution of precision medicine. Cancer is no longer considered a single disease, but rather, a diverse array of diseases wherein each patient has a unique collection of germline variants and somatic mutations. Molecular profiling of patient-derived samples has led to a data explosion that could help us understand the contributions of environment and germline to risk, therapeutic response, and outcome. To maximize the value of these data, an interdisciplinary approach is paramount. The National Cancer Institute (NCI) has initiated multiple projects to characterize tumor samples using multi-omic approaches. These projects harness the expertise of clinicians, biologists, computer scientists, and software engineers to investigate cancer biology and therapeutic response in multidisciplinary teams. Petabytes of cancer genomic, transcriptomic, epigenomic, proteomic, and imaging data have been generated by these projects. To address the data analysis challenges associated with these large datasets, the NCI has sponsored the development of the Genomic Data Commons (GDC) and three Cloud Resources. The GDC ensures data and metadata quality, ingests and harmonizes genomic data, and securely redistributes the data. During its pilot phase, the Cloud Resources tested multiple cloud-based approaches for enhancing data access, collaboration, computational scalability, resource democratization, and reproducibility. These NCI-led efforts are continuously being refined to better support open data practices and precision oncology, and to serve as building blocks of the NCI Cancer Research Data Commons.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Pharmacological research and precision cancer medicine: A call for manuscripts
    Cho, Kei
    Clementi, Emilio
    Levi-Schaffer, Francesca
    Smalley, Keiran S. M.
    Radice, Sonia
    Watts, Stephanie W.
    PHARMACOLOGICAL RESEARCH, 2015, 102 : 308 - 309
  • [22] Statistical issues and advances in cancer precision medicine research
    Nasution, Marlina D.
    Wang, Xiaofei
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (02) : 215 - 216
  • [23] Global Inequities in Precision Medicine and Molecular Cancer Research
    Drake, Thomas M.
    Knight, Stephen R.
    Harrison, Ewen M.
    Soreide, Kjetil
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [24] Perspectives on research activity in the USA on Cancer Precision Medicine
    Bando, Hideaki
    Takebe, Naoko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (02) : 106 - 110
  • [25] Challenges of basic research for precision medicine for pancreatic cancer
    Tateishi, Keisuke
    CANCER SCIENCE, 2024, 115 : 1665 - 1665
  • [26] Big data in basic and translational cancer research
    Peng Jiang
    Sanju Sinha
    Kenneth Aldape
    Sridhar Hannenhalli
    Cenk Sahinalp
    Eytan Ruppin
    Nature Reviews Cancer, 2022, 22 : 625 - 639
  • [27] Editorial: Medical big data in cancer research
    Mao, Jingxin
    Zheng, Ke
    Weng, Xiong
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [28] Big data and artificial intelligence in cancer research
    Wu, Xifeng
    Li, Wenyuan
    Tu, Huakang
    TRENDS IN CANCER, 2024, 10 (02) : 147 - 160
  • [29] Big data in basic and translational cancer research
    Jiang, Peng
    Sinha, Sanju
    Aldape, Kenneth
    Hannenhalli, Sridhar
    Sahinalp, Cenk
    Ruppin, Eytan
    NATURE REVIEWS CANCER, 2022, 22 (11) : 625 - 639
  • [30] Analysis and Modeling for Big Data in Cancer Research
    Niu, Bing
    Li, Jianxin
    Li, Guozheng
    Poon, Simon
    Harrington, Peter B.
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017